EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Real-World Data-Derived Pharmacovigilance on Drug-Induced Cognitive Impairment Utilizing a Nationwide Spontaneous Adverse Reporting System

Yongjun Sunwoo, Sae Hyun Eom, Ji Seong Yun, Yujin Kim, Jeongmin Lee, Soo Hyeon Lee, Sooyoung Shin iD, Yeo Jin Choi iD

Medicina · 2024

DOI: 10.3390/medicina60071028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medicina, 2024. Verfasst von Yongjun Sunwoo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Regulatory Science, Graduate School, Kyung Hee University, Seoul 02447, Republic of Korea. Hauptthemen laut MEDLINE: Cognitive Dysfunction, Pharmacovigilance, Adverse Drug Reaction Reporting Systems. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, Ministry of Science and ICT, Ministry of Food and Drug Safety.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives: Despite high incidences of cognitive impairment with aging, evidence on the prevalence and the seriousness of drug-induced cognitive impairment is limited. This study aims to evaluate the prevalence and the severity of drug-induced cognitive impairment and to investigate the clinical predictors of increased hospitalization risk from serious drug-induced cognitive impairment. Materials and Methods: Adverse drug events (ADEs) regarding drug-induced cognitive impairment reported to the Korean Adverse Event Reporting System Database (KAERS DB) from January 2012 to December 2021 were included (KIDS KAERS DB 2212A0073). The association between the etiologic classes and the reporting serious adverse events (SAEs) was evaluated using disproportionality analysis, and the effect was estimated with reporting odds ratio (ROR). Clinical predictors associated with increased risk of hospitalization from SAEs were identified via multivariate logistic analysis, and the effect was estimated with odds ratio (OR).

Results

The most etiologic medication class for drug-induced cognitive impairment ADEs was analgesics, followed by sedative-hypnotics. Anticancer (ROR 57.105, 95% CI 15.174–214.909) and anti-Parkinson agents (ROR 4.057, 95% CI 1.121–14.688) were more likely to report serious drug-induced cognitive impairments. Male sex (OR 19.540, 95% CI 2.440–156.647) and cancer diagnosis (OR 18.115, 95% CI 3.246–101.101) are the major clinical predictors for increased risk of hospitalizations due to serious drug-induced cognitive impairment.

Conclusions

This study highlights the significant prevalence and severity of drug-induced cognitive impairment with cancer diagnosis and anticancer agents. However, further large-scaled studies are required because of the potential underreporting of drug-induced cognitive impairments in real practice settings, which is further contributed to by the complexity of multiple contributing factors such as comorbidities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cognitive DysfunctionPharmacovigilanceAdverse Drug Reaction Reporting SystemsHumansMaleFemaleRepublic of KoreaMiddle AgedAgedAdultDrug-Related Side Effects and Adverse ReactionsPrevalenceHospitalizationAdolescentAged, 80 and over

Stichwörter der Autor:innen

Parkinson’s diseasecancerchemotherapycognitive impairmentpharmacovigilancereal-world data

Autor:innen und Institutionen

  • Department of Regulatory Science, Graduate School, Kyung Hee University, Seoul 02447, Republic of Korea.
  • Institute of Regulatory Innovation through Science (IRIS), Kyung Hee University, Seoul 02447, Republic of Korea.
  • Department of Pharmacy, College of Pharmacy, Kyung Hee University, Seoul 02447, Republic of Korea.
  • Department of Pharmacy, College of Pharmacy, Ajou University, Suwon 16499, Republic of Korea.
  • Research Institute of Pharmaceutical Science and Technology (RIPST), Ajou University, Suwon 16499, Republic of Korea.

ORCID-Profile: Sooyoung Shin, Yeo Jin Choi

Förderung

  • Ministry of Education
  • Ministry of Science and ICT
  • Ministry of Food and Drug Safety
  • Ministry of Food and Drug Safety in 2024

Zitieren

APA

Sunwoo, Y., Eom, S. H., Yun, J. S., Kim, Y., Lee, J., Lee, S. H., Shin, S., & Choi, Y. J. (2024). Real-World Data-Derived Pharmacovigilance on Drug-Induced Cognitive Impairment Utilizing a Nationwide Spontaneous Adverse Reporting System. Medicina. https://doi.org/10.3390/medicina60071028

Vancouver

Sunwoo Y, Eom SH, Yun JS, Kim Y, Lee J, Lee SH, et al. Real-World Data-Derived Pharmacovigilance on Drug-Induced Cognitive Impairment Utilizing a Nationwide Spontaneous Adverse Reporting System. Medicina. 2024. doi:10.3390/medicina60071028

BibTeX
@article{Sunwoo2024,
  author = {Sunwoo, Yongjun and Eom, Sae Hyun and Yun, Ji Seong and Kim, Yujin and Lee, Jeongmin and Lee, Soo Hyeon and Shin, Sooyoung and Choi, Yeo Jin},
  title = {Real-World Data-Derived Pharmacovigilance on Drug-Induced Cognitive Impairment Utilizing a Nationwide Spontaneous Adverse Reporting System},
  journal = {Medicina},
  year = {2024},
  doi = {10.3390/medicina60071028}
}
Kostenlos starten →